@the_uber_dog: Priceless interaction 😆 New episode out now! Full video on my YouTube #LinkInBio #uberdog #theuberdog #explore #foryou #foryoupage #trending #viral #dogsoftiktok #fyp #cuteanimals #dogs #cuboulder #colorado

Kevin & Bowie
Kevin & Bowie
Open In TikTok:
Region: US
Friday 03 January 2025 00:09:00 GMT
4916163
318062
1882
21569

Music

Download

Comments

hackslord0
Legion :
Bowie be like “the ladies want me 😩 fear me human “❤️
2025-01-03 07:25:41
14877
t.mariepole
t.mariepole :
15 years ago, we were told not to fall for the “I have a puppy in my car, wanna see?” bit from strangers 😂
2025-01-03 16:26:20
9326
kat.atomic
Kat Davenport :
That's actually quite smart. Bowie's presence will keep him safe as well as make people smile. 😁
2025-01-03 11:07:38
7119
kimmigirl77
kimmigirl77 :
Just more proof that DOGS make life so much better ❤️❤️❤️
2025-01-03 03:09:16
3048
chiefboss87
John Smith :
love how respectful the ladies are asking before just petting the good boy
2025-01-03 14:39:08
4014
wuboito
Wuboito :
Bros playing chess.
2025-01-03 04:42:10
5979
hivanic
helen :
I’ll pay $50 for this ride. ❤️❤️
2025-01-03 08:35:35
1794
yazziyazziyazzi
Yazzi 🕊 :
So w Uber dog the owner just brings them along for the ride & the Uber is cheaper? Coz if so I’m signing up every time LOL
2025-01-03 09:27:42
79
To see more videos from user @the_uber_dog, please go to the Tikwm homepage.

Other Videos

I want to share a study being presented as a poster at #SABCS24 by Dr. Savannah Roy and her team (Abstract Number: SESS-2438) looking at the incidence of major adverse cardiovascular events (MACE) (heart attack, stroke arrhythmia or heart failure) in postmenopausal and premenopausal women with hormone receptor-positive breast cancer/HER2 negative undergoing endocrine therapy.  Here are the key points that I go into the video: 📌 The association of cardiovascular events with aromatase inhibitors has been controversial.  📌 This analysis looked at over 26,000 postmenopausal women with HR+/HER2- breast cancer diagnosed at age >65 and premenopausal women diagnosed at age <45 and experiencing premature menopause or undergoing ovarian function suppression. 📌 Patients with HER2-positive breast cancer were excluded to avoid the additional confounder of potential cardiotoxicity from HER2 targeted agents.  ⁉️ What did they find? ⭐️ In postmenopausal women with HR+/HER2- breast cancer, AI treatment was not associated with increased risk of cardiac outcomes compared to tamoxifen.  ⭐️ There was a lower proportion of cardiac events in women with premature menopausal or those undergoing OFS (3.54%) compared to postmenopausal women (28%).  ⭐️ The follow-up was a little under 5 years so we absolutely need longer follow-up but this is very helpful information especially in the short-term.  ⁉️ Let me know your questions on this study or on cardiac toxicity and breast cancer medications in general and will see what I can answer!  #breastcancer #cardiac #heartdisease
I want to share a study being presented as a poster at #SABCS24 by Dr. Savannah Roy and her team (Abstract Number: SESS-2438) looking at the incidence of major adverse cardiovascular events (MACE) (heart attack, stroke arrhythmia or heart failure) in postmenopausal and premenopausal women with hormone receptor-positive breast cancer/HER2 negative undergoing endocrine therapy. Here are the key points that I go into the video: 📌 The association of cardiovascular events with aromatase inhibitors has been controversial. 📌 This analysis looked at over 26,000 postmenopausal women with HR+/HER2- breast cancer diagnosed at age >65 and premenopausal women diagnosed at age <45 and experiencing premature menopause or undergoing ovarian function suppression. 📌 Patients with HER2-positive breast cancer were excluded to avoid the additional confounder of potential cardiotoxicity from HER2 targeted agents. ⁉️ What did they find? ⭐️ In postmenopausal women with HR+/HER2- breast cancer, AI treatment was not associated with increased risk of cardiac outcomes compared to tamoxifen. ⭐️ There was a lower proportion of cardiac events in women with premature menopausal or those undergoing OFS (3.54%) compared to postmenopausal women (28%). ⭐️ The follow-up was a little under 5 years so we absolutely need longer follow-up but this is very helpful information especially in the short-term. ⁉️ Let me know your questions on this study or on cardiac toxicity and breast cancer medications in general and will see what I can answer! #breastcancer #cardiac #heartdisease

About